Nevada Senate Passes Bill to Force Diabetes Drug Manufacturers to Disclose Pricing Practices - TheStreet.com


TheStreet.com

Nevada Senate Passes Bill to Force Diabetes Drug Manufacturers to Disclose Pricing Practices
TheStreet.com
A bill forcing diabetes drug makers to shed light on their insulin pricing, profits and costs passed the Nevada Senate. The bill would also force insulin drug makers like Sanofi (SNY) , Novo (NVO) and Eli Lilly (LLY) to pre announce when they will ...

and more »